The unmet palliative care needs of those dying with dementia

Laura Dempsey1, Maura Dowling, Philip Larkin

  • 1Lecturer and Programme Director for the Postgraduate Diploma in Nursing (Palliative Care).

Insights

Millions with dementia need better end-of-life care (EoLC). Despite advances, many with end-stage dementia receive inadequate care due to diagnostic challenges and lack of provider education, impacting palliative care access.

Area of Science:

  • Gerontology
  • Neurology
  • Palliative Care Medicine

Background:

  • An estimated 33.9 million individuals globally live with dementia.
  • Survival post-dementia onset averages 4.1 years for men and 4.6 years for women.
  • Existing literature indicates suboptimal end-of-life care (EoLC) for individuals with end-stage dementia.

Purpose of the Study:

  • To highlight the critical unmet end-of-life care needs of people with dementia.
  • To identify barriers preventing adequate EoLC for this population.
  • To underscore the disparity in palliative care referrals for dementia patients.

Main Methods:

  • Literature review on dementia care and end-of-life challenges.
  • Analysis of factors contributing to inadequate EoLC.
  • Comparison of palliative care access for dementia patients versus other terminal illnesses.

Main Results:

  • People with end-stage dementia frequently do not receive adequate or appropriate EoLC.
  • Barriers include diagnostic difficulties, stigma, and insufficient healthcare provider education on dementia complications.
  • Dementia patients are referred to palliative care services less often than other terminally ill patients.

Conclusions:

  • Effective EoLC for dementia patients remains a significant challenge.
  • Addressing diagnostic and educational barriers is crucial for improving care.
  • Increased access to appropriate palliative care services is vital for this vulnerable group.

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.1K
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
2.9K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
728
Kubler Ross's Stages of Dying01:21

Kubler Ross's Stages of Dying

Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K